Indexado em
- Abra o Portão J
- Genamics JournalSeek
- Chaves Acadêmicas
- RefSeek
- Universidade de Hamdard
- EBSCO AZ
- OCLC- WorldCat
- publons
- Fundação de Genebra para Educação e Pesquisa Médica
- Google Scholar
Links Úteis
Compartilhe esta página
Folheto de jornal
Periódicos de Acesso Aberto
- Agro e Aquicultura
- Alimentos e Nutrição
- Bioinformática e Biologia de Sistemas
- Bioquímica
- Ciência de materiais
- Ciencias ambientais
- Ciências Clínicas
- Ciências Farmacêuticas
- Ciências gerais
- Ciências Médicas
- Cuidados de enfermagem e saúde
- Engenharia
- Genética e Biologia Molecular
- Gestão de negócios
- Imunologia e Microbiologia
- Neurociência e Psicologia
- Química
Abstrato
A Review of Fatty Liver/NASH and Liver Cirrhosis: Genetics, Prevention, Nutritional, Behavioral Modification, Exercise, Pharmaceutical, Biophysics and Biotech Therapy
Trent W.Nichols Jr
This article reviews the current factors concerning obesity, metabolic syndrome or DM2 and the accumulation of fat which can result in fatty liver or steatohepatitis (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH) and cirrhosis. The pathophysiology is discussed as well as the current treatment and nutritional options of betaine, SAMe, phosphatidylcholine, silymarin with vitamin E and probiotics. Since obesity, metabolic syndrome and NAFLD/NASH are polygenic as well as epigenetic, the current nutritional, pharmaceutical and biotec solutions are fairly limited. Future options may include biophysical such as temperature control, light therapy ormelatonin and moderate magnetic field therapy capable of regulating over 2500 genes as well as novel can nabinoidagents and polyphenols.